Evofem Biosciences has announced that two new data sets from its Phase 3 AMPOWER trial evaluating Phexxi (lactic acid, citric acid, potassium bitartrate) will be presented at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting (ACSM). The meeting will be conducted virtually from April 30 – May 2, 2021. “These new data sets provide clinical insights into how women used Phexxi…
Earlier today Mirvie announced it is making rapid progress toward developing a simple, personalized blood test with the potential for early detection of pregnancy complications, such as preterm birth, preeclampsia and gestational diabetes, which affect 1 in 5 women. Currently, there is no reliable way to identify if a mother is at risk for these significant pregnancy complications. Pregnancy complications, such as…
All Raise was initially born our of a grassroots movement in 2017 to arm women with access guidance and support to advance their professional growth. Today the organization is on a mission to accelerate the success of female founders and funders to build a more prosperous, equitable future. Yesterday All Raise published its latest Annual Report and truly 2020 wasn’t a great…
Rhia Ventures is on a mission is to create a vibrant U.S. market for sexual, reproductive, and maternal health that produces equitable outcomes for all. The firm makes direct investments in early- and growth-stage companies, provides technical assistance and resources to portfolio companies, and organizes corporate engagement programs to change social norms, practices, and people that influence the market. Yesterday the firm announced…
Today, Real Housewives of Atlanta star Cynthia Bailey-Hill announced her support for Responsum for Fibroids, an online empowerment, knowledge, and support platform for women with uterine fibroids, a condition that affects 70-80% of all women by the age of 50. Provided in partnership with CARE About Fibroids and The White Dress Project—two of the nation’s leading fibroids support organizations—and underwritten with independent support from AbbVie, a global…
I’m on a mission to start the conversation ‘how can femtech help the NHS’ but of course there are so many organisations that could benefit. Take, for example, private healthcare providers that need to be on the front foot to maintain their competitive edge. In the UK the private healthcare offer has traditionally focused on access, choice, continuity of care, facilities and…
The United Health Foundation, the philanthropic foundation of UnitedHealth Group (NYSE: UNH), is partnering with Touro University Nevada (Touro) to improve access to high-quality prenatal care for underserved and homeless women in southern Nevada. The three-year, $2.6 million partnership will help reduce maternal health disparities and increase the state’s OB-GYN and family medicine physician workforce. According to America’s Health Rankings’ latest Health of…
Roche today announced U.S. Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel for advanced or recurrent endometrial cancer patients. MMR is a molecular mechanism that functions to correct certain errors that can spontaneously occur during DNA replication. Testing can identify patients eligible for treatment with JEMPERLI (dostarlimab-gxly) monotherapy, an anti-PD1 immunotherapy from GlaxoSmithKline (GSK) that was approved by…
